Comera Life Sciences Holdings, Inc.
CMRA
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -52.57% | 43.11% | 16.25% | 3.71% | 66.13% |
| Total Depreciation and Amortization | -7.26% | -12.37% | 18.91% | 0.00% | 10.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.93% | -24.55% | 186.58% | -65.53% | -94.61% |
| Change in Net Operating Assets | -123.18% | -31.78% | -72.67% | 158.58% | -68.69% |
| Cash from Operations | -92.65% | 47.87% | -3.14% | 22.67% | 10.34% |
| Capital Expenditure | 100.00% | 93.55% | -- | 100.00% | -620.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 93.55% | -- | 100.00% | -620.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -209.37% | 86.17% | 0.00% | 24.68% | -- |
| Issuance of Common Stock | -- | -- | 2,426.18% | -89.25% | -78.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,172.15% | -104.00% | 39.79% | 678.65% | -96.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 221.57% | -156.87% | 42.32% | 68.40% | -310.97% |